OIE standards for vaccines and future trends

OIE Revue Scientifique et Technique

Volumn 26, Issue 2, 2007, Pages 373-378

  Edwards, S ^a,b  

^a VETERINARY LABORATORIES AGENCY   (United Kingdom)

^b OIE Biological Standards Commission   (United Kingdom)

Author keywords

Biotechnology; Differentiating infected from vaccinated animals (DIVA) strategy international standard; Quality control; Safety; Vaccine; Vaccine bank

Indexed keywords

ANIMALIA; APOIDEA; AVES; MAMMALIA;

EID: 34548299484     PISSN: 02531933     EISSN: 16080645     Source Type: Journal    
DOI: 10.20506/rst.26.2.1749     Document Type: Article

References (14)

1. Capua I., Cauoli G., Marangon S., Bortolotti L. & Ortali G. (2002). - Strategies for the control of avian influenza in Italy Vet. Rec., 150, 223.
2. Commission of the European Communities (2001). - Directive 2001/82/EC of the European Parliament and of the Council of 6 November 2001 on the Community code relating to veterinary medicinal products. Off. J. Eur. Communities, L 311, 1-66.
3. Council of Europe (COE) European Directorate for the Quality of Medicines (EDQM) (2005). - European pharmacopoeia, 5th Ed. COE. Strasbourg.
4. Jones P.W., Dougan G., Howard C., Mackenzie N., Collins P. & Chatfield S.N. (1991). - Oral vaccination of calves against experimental salmonellosis using a double aro mutant of Salmonella typhimurium. Vaccine, 9, 29-34.
5. Mackay D.K.J., Forsyth M.A., Davies P.R., Berlinzani A., Belsham G.J., Flint M. & Ryan M.D. (1997). - Differentiating infection from vaccination in foot-and-mouth disease using a panel of recombinant, non-structural proteins in ELISA. Vaccine, 16, 446-459.
6. Nobiron I., Thompson I., Brownlie J. & Collins M.E. (2003). - DNA vaccination against bovine viral diarrhoea virus induces humoral and cellular responses in cattle with evidence for protection against viral challenge. Vaccine, 21, 2091-2101.
7. Pastoret P.-P. & Brochier B. (1996). - The development and use of vaccinia-rabies recombinant oral vaccine for the control of wildlife rabies: a link between Jenner and Pasteur. Epidemiol. Infect., 116, 235-240.
8. Taylor J., Trimarchi C., Weinberg R., Languet B., Guillemin E., Desmettre P. & Paoletti E. (1991). - Efficacy studies on a canary pox-rabies recombinant virus. Vaccine. 9, 190-193.
9. United States Department of Agriculture (USDA) (2001). - Code of Federal Regulations, Title 9, Animals and animal products, Part 11.3, Standard requirements. US Government Printing Office, Washington, DC, USA.
10. Van Oirschot J.T., Terpstra C., Moormann R.J.M., Berns A.J.M. & Gielkens A.L.J. (1990). - Safety of an Aujeszky's disease vaccine based on deletion mutant strain 783 which does not express thymidine kinase and glycoprotein 1. Vet. Rec., 127, 443-446.
11. Van Oirschot J.T., Kaashoek M.J. & Rijsewijk E.A.M. (1996). - Advances in the development and evaluation of bovine herpesvirus 1 vaccines. Vet. Microbiol., 53, 43-54.
12. Van Rijn P.A., Van Gennip H.G. & Moormann R.J. (1999). - An experimental marker vaccine and accompanying serological diagnostic test both based on envelope glycoprotein E2 of classical swine fever virus (CSFV). Vaccine, 17, 433-440.
13. World Organisation for Animal Health (OIE) (2004). - Manual of Diagnostic Tests and Vaccines for Terrestrial Animals, 5th Ed. OIE, Paris.
14. World Organisation for Animal Health (OIE) (2006). - Terrestrial Animal Health Code, 15th Ed. OIE, Paris.